Victory Capital Management
NEXI

Victory Capital Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Victory Capital Management’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-479
Closed -$181K – 2866
2021
Q3 		$181K Buy
479
+8
+2% +$2.68K ﹤0.01% 2536
2021
Q2 		$192K Buy
471
+29
+7% +$13.4K ﹤0.01% 2533
2021
Q1 		$211K Buy
+442
New +$241K ﹤0.01% 2517

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Victory Capital Management's NEXI Position: Q4 2021 in Review

Victory Capital Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2021, closing a stake of 479 shares — an estimated $181K sold.

Victory Capital Management first reported a position in NEXI in Q1 2021 and held it in 3 quarters. The position peaked at $211K in Q1 2021. 46 funds tracked by Wall St. Rank hold NEXI as of Q4 2021.

  • Victory Capital Management reported no remaining NexImmune, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Victory Capital Management sold 479 NexImmune, Inc. Common Stock shares in Q4 2021, an estimated $181K.
  • Victory Capital Management first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Victory Capital Management's NexImmune, Inc. Common Stock position peaked at $211K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2021.

Based on Victory Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.